Home » Healthcare » Drug Discovery Informatics Market

Drug Discovery Informatics Market By Software Solutions (Chemoinformatics Software, Bioinformatics Software, LIMS (Laboratory Information Management System), Data Mining and Visualization Software); By Services (In-House Informatics Services, Outsourced Services); By Database Management (Chemical Databases, Biological Databases); By Mode of Informatics (Structure-Based Drug Design, Ligand-Based Drug Design, Target-Based Drug Design); By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs)); By Application (Hit Identification and Validation, Lead Generation and Optimization, Preclinical and Clinical Development Support, Personalized Medicine and Biomarker Discovery); By Integration with Other Technologies (Artificial Intelligence (AI) and Machine Learning (ML), High-Throughput Screening (HTS), Omics Technologies); By Region – Growth, Future Prospects & Competitive Analysis, 2023 – 2030

Summary
Table Of Content

Market Insights

The global demand for drug discovery informatics was valued at USD 3215.5 Million in 2022 and is expected to reach USD 7681.5 Million in 2030, expanding at a CAGR of 11.5% between 2023 and 2030.
The structure-based drug design segment is the market leader by mode of informatics, accounting for more than 40% of total value in 2022, while the target-based drug design category is estimated to grow rapidly in the projection period.
The outsourced services category is expected to expand rapidly in the forecast period, while the in-house informatics services segment has the highest market share in 2022.
Chemical database management dominates the global demand for drug discovery informatics, accounting for over 55% of the market share in 2022.
The data mining and visualization software category is expected to expand the fastest throughout the forecast timeline, while the bioinformatics software solutions had a market share of more than 30% in 2022.
With a more than 28% market share in 2022 and strong CAGR growth prospects, the hit identification and validation application segment will likely continue to lead the global market needs for drug discovery informatics.
Pharmaceutical and biotechnology companies dominated the market, with 38% of the total revenue share by end-users.
North America accounted for over one-third of the drug discovery informatics industry in 2022, while Asia Pacific and Europe contributed just under 54%. Europe had a market revenue share of more than 20% in 2022.
Drug discovery informatics supports every phase of the drug discovery procedure, from target identification to preclinical research and clinical trials.
Drug discovery informatics assists researchers in identifying new drug targets and developing better drugs more quickly and efficiently, as well as allowing researchers to exchange data and collaborate more effectively across fields.
Government initiatives and funding support for research and development in drug discovery informatics contribute to the market’s growth, with various regions promoting innovation in pharmaceutical research.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Executive Summary

Market Definition

The drug discovery informatics market involves the application of computational methods, informatics tools, and data analysis techniques to streamline and enhance the drug discovery and development process. This dynamic industry encompasses various components, including computational chemistry for modeling molecular interactions, bioinformatics for interpreting biological data, and chemoinformatics for managing chemical information. The market aims to accelerate and improve the efficiency of pharmaceutical research, leading to the discovery of novel therapeutic agents and advancements in personalized medicine.

Market Overview

The global drug discovery informatics market has witnessed rapid growth in recent years and is predicted to grow at a CAGR of 11.5% between 2023 and 2030. The market was valued at USD 3215.5 million in 2022 and is anticipated to reach USD 7681.5 million in 2030.

Drug discovery informatics is the use of information technology to assist researchers in the drug discovery and development process. The approach necessitates using computational methodologies and tools such as AI and advanced software to analyze enormous quantities of biological data to identify potential medication candidates. Pharmaceutical businesses heavily rely on data-driven informatics tools to help them with lead identification, pre-clinical research, and compound screening. They examine trends, evaluate hypotheses, and assess the effectiveness of therapies using this data. As per the survey by Evaluate Pharma, the top 11 pharmaceutical companies in the globe spent more than US$ 104.0 billion on research and development in 2022, making up 42% of all pharmaceutical research expenditures worldwide.

Increased investment in drug R&D activities with long-term strategic goals contributes to establishing a framework for integrating public data with internal datasets and frameworks. It also enables ML and AI technologies to train on well-managed datasets, assisting in standardizing and centralizing sensitive data for improved results. The U.S. Information Technology & Innovation Foundation estimates that innovations in data science will allow pharmaceutical companies to save almost USD 5.4 billion annually on R&D expenses. These developments are increasing the global market value of drug discovery informatics.

Segmentation by Software Solutions

The data mining and visualization software segment will likely have the greatest CAGR, owing to the increasing need for advanced data analysis and visualization tools in drug discovery processes.
Bioinformatics software solutions hold the largest market share, accounting for over 30% in 2022, attributed to the major role of bioinformatics in processing and interpreting biological data.

Segmentation by Services

The outsourced services segment is expected to achieve the largest CAGR due to the increasing market trend of organizations outsourcing informatics services to specialized service providers, allowing them to focus on core competencies.
In-house informatics services presently lead the market share with over 58% in 2022. Many organizations commonly prefer maintaining in-house capabilities for critical aspects of drug discovery informatics, allowing them greater control over data security, customization, and integration with internal processes.

Segmentation by Database Management

Chemical databases dominate the database management category, satisfying more than 55% of the global demand for drug discovery informatics in 2022. This dominance is attributed to the critical role of chemical information in virtual screening and compound optimization.
Biological databases are poised to achieve a high CAGR over the upcoming years, driven by the emerging market focus on genomics, proteomics, and other biological data for drug discovery.

Segmentation by Mode of Informatics

The target-based drug design category will post a high market CAGR. Target-based approaches involve identifying specific biological targets, such as proteins or nucleic acids, and designing drugs to interact with these targets, making it a crucial strategy in rational drug design.
The Structure-based drug design segment leads the market share with over 40% in 2022. This approach relies on the knowledge of the three-dimensional structure of a biological target to design molecules that fit and interact optimally, providing a rational and efficient approach to drug discovery.

Segmentation by End-User

The contract research organizations (CROs) segment is anticipated to register the largest CAGR. As drug discovery becomes more complex, CROs play a crucial role in providing specialized services, expertise, and infrastructure, making them an attractive option for companies looking to streamline their research processes.
Pharmaceutical and biotechnology companies currently lead with a market revenue share of nearly 38% in 2022. These organizations heavily rely on informatics tools for pre-clinical research and development, compound screening, target identification, lead identification, and speeding up their drug discovery process.

Segmentation by Application

The personalized medicine and biomarker discovery segment will witness a high CAGR as the industry increasingly focuses on tailoring treatments to individual patients, necessitating advanced informatics tools for patient data analysis.
The hit identification and validation lead the global market share, holding over 28% in 2022. This application involves the early-stage identification and validation of potential drug candidates, making it a critical phase in drug discovery.

Segmentation by Integration with Other Technologies

Integration with AI and ML technologies dominates the global market share for drug discovery informatics, accounting for more than 55% in 2022. AI and ML enhance data analysis, predictive modeling, and pattern recognition, revolutionizing decision-making processes in drug discovery.
The rest of the market demands are derived from high-throughput screening (HTS) and omics technologies. HTS facilitates the rapid testing of large compound libraries, while omics technologies provide comprehensive insights into biological systems, collectively contributing to a holistic approach to drug discovery.

Segmentation by Region

North America stands out as a notably profitable region for industry players, accounting for over one-third of the share in 2022. This regional dominance is attributed to its robust pharmaceutical and biotechnology sectors and significant R&D investments, creating a favorable environment for adopting informatics.
Europe and Asia Pacific contributed under 54% of the share in 2022, with Europe demonstrating a robust market presence exceeding 20%. Asia Pacific showcases significant market growth potential, owing to the increasing research activities, healthcare advancements, and supportive government initiatives in countries like India and China.
The rest of the world, including Latin America, the Middle East, and Africa, fulfills the remaining demand for drug discovery informatics with diverse regional dynamics and growth opportunities. In these regions, emerging economies and increasing investments in healthcare infrastructure contribute to the adoption of drug discovery informatics.

The emerging adoption of in-silico modeling techniques, developments in high-performance computing and web-based services, the growing number of drug discovery data, and a need for innovative drug molecules are key factors propelling the global drug discovery informatics market growth.

In 2022, North America held the majority of the revenue share in the global drug discovery informatics market. The region has a robust pharmaceutical and biotechnology industry, housing numerous key players and research institutions actively engaged in drug discovery efforts. The presence of a well-established healthcare infrastructure, substantial research and development investments, and a skilled workforce contribute to North American market leadership in adopting and integrating advanced informatics solutions. Besides, a supportive regulatory environment and initiatives promoting technological innovation further propel the growth of the drug discovery informatics market in the region. The United States, in particular, stands out as a major contributor to this market dominance, with its thriving life sciences sector and a higher concentration of pharmaceutical companies driving the adoption of informatics tools to enhance drug discovery processes.

The Asia Pacific will likely experience the most rapid growth in the drug discovery informatics industry over the projection period. The region has witnessed a surge in pharmaceutical and biotechnology activities, with countries like China and India emerging as key players in drug discovery research and development. Increasing investments in healthcare infrastructure, rising government initiatives supporting life sciences research, and a growing pool of skilled researchers further fuel the regional adoption of advanced informatics tools. This region also offers a vast patient population for clinical trials, making it an attractive destination for pharmaceutical companies looking to expand their research efforts.

Key Highlights of the Report

The global drug discovery informatics market is segmented by software solutions, services, database management, mode of informatics, end-user, application, integration with other technologies, and region. The data mining and visualization software segment is anticipated to show substantial development, aligning with the increasing demand for advanced tools in data analysis. In the services segment, outsourced services are anticipated to experience substantial growth, owing to the industry’s inclination towards external expertise. Within database management, chemical databases play a dominant role, meeting the majority of the global demand for drug discovery informatics. The integration with AI and ML technologies takes center stage, representing the market’s adoption of cutting-edge computational methods.

Research in pharmaceuticals and life sciences produces enormous amounts of data every day. Research groups and scientists continue to encounter significant challenges in managing and turning this generated data into useful information for therapeutic decisions. Drug discovery informatics technologies play an important role in data integration, data organization, and data retrieval. The global market for drug discovery informatics is predicted to increase rapidly in the coming years. This can be ascribed to various factors, including developments in efficient computing and web services, increased acceptance of in-silico modeling methods, the expanding volume of data in drug discovery, and a growing need for novel therapeutic compounds.

North America is regarded as the most technologically advanced region and has been a major contributor to the expansion of the drug discovery informatics sector. Furthermore, numerous firms in this sector have resulted in major technological advances and product developments. The region is home to several well-established CROs, which serve to increase demand for informatics services. Furthermore, increased R&D investments in North America positively boost market growth. According to a report issued in December 2022 by the Pharmaceutical Research and Manufacturers of America (PhRMA), PhRMA members alone invested hundreds of billions of dollars in drug research and development (R&D) over the years, including a record USD 102 billion in 2021.

What Are The Main Drivers Of The Global Drug Discovery Informatics Market?

The increasing demand for novel and more effective drugs and a rising emphasis on personalized medicine fuels the global adoption of drug discovery informatics tools and technologies. Advances in computational methods, artificial intelligence, and big data analytics play a major role in expediting drug discovery, enabling researchers to analyze vast datasets, predict potential drug candidates, and optimize research strategies. Moreover, the need for more efficient and cost-effective approaches to drug discovery, coupled with regulatory support for digital technologies, also contributes to the overall expansion of the drug discovery informatics market.

What Are The Major Challenges Faced By The Global Drug Discovery Informatics Market?

The higher costs associated with implementing and maintaining advanced informatics systems can be a market barrier, particularly for smaller research entities. Data privacy concerns and the regulatory landscape add another layer of market complexity, requiring robust security measures and compliance with stringent guidelines. In addition, the rapid pace of technological advancements requires continuous adaptation, further putting pressure on market players to keep up with evolving informatics tools and methodologies.

What Are The Growth Opportunities In The Global Drug Discovery Informatics Market?

Integrating AI and ML technologies offers substantial market potential for accelerating drug discovery processes by predicting potential drug candidates and optimizing research strategies. An increased focus on precision medicine and personalized treatments creates market opportunities for informatics solutions tailored to individual patient profiles. The expanding role of informatics in managing and analyzing real-world data, along with the adoption of cloud-based solutions for improved accessibility and collaboration, opens avenues for market developments. Besides, the rising prevalence of rare diseases and the need for innovative treatments provide a niche for drug discovery informatics applications.

Market Drivers

Several factors drive the global drug discovery informatics market. The primary drivers of the global drug discovery informatics market are as follows:

Increased Adoption of AI and ML Technologies

AI and machine learning (ML) technologies are rapidly incorporated into drug research informatics to improve efficiency and accuracy. These technologies allow for sophisticated data analysis, predictive modeling, and virtual screening, resulting in faster drug discovery processes and higher success rates. In detail, AI algorithms can analyze diverse biological data types, including genomics, proteomics, and chemical structures, to uncover meaningful insights. ML models can predict the likelihood of success for specific drug candidates, optimizing the selection of compounds for further development. The ability of AI and ML to handle complex data sets and provide predictive modeling contributes to quicker and more informed decision-making in drug discovery informatics.

Pharma companies use a variety of approaches to increase the use of AI in drug discovery informatics for drug discovery, formulation design, and drug development. For instance, in January 2022, the Chinese healthcare group Shanghai Fosun Pharmaceutical (Fosun Pharma) and the US-based artificial intelligence (AI) drug research and development company Insilico Medicine signed a collaboration agreement to use AI technology to advance the discovery and development of drugs targeting various targets.

Market Restraints

The global drug discovery informatics market faces challenges that may hinder its growth. These include the following:

High Implementation Costs and Infrastructure Challenges

The implementation of advanced drug discovery informatics solutions involves substantial costs, including software licenses, hardware infrastructure, and ongoing maintenance expenses. Smaller research organizations, academic institutions, or those in emerging markets face financial constraints, limiting their ability to adopt sophisticated informatics tools. Moreover, integrating these solutions with existing laboratory information management systems (LIMS) and other technologies requires significant investment and may lead to compatibility challenges. The high upfront costs and potential disruptions during the integration phase act as a market restraint, especially for organizations with modest financial resources or outdated infrastructure, impeding widespread adoption and accessibility of drug discovery informatics tools.

Opportunities

The global drug discovery informatics market offers major growth opportunities. These include the following:

Integration of Quantum Computing

The integration of quantum computing in drug discovery informatics presents a leading market development opportunity for advancing computational capabilities. Quantum computing can handle complex calculations and simulations that are currently challenging for classical computers. In drug discovery, quantum computing can be utilized to model intricate molecular interactions and simulate chemical reactions with unprecedented accuracy and speed. This capability allows researchers to explore a broader chemical space, accelerating the identification of potential drug candidates.

Quantum computing’s ability to handle the intricate calculations involved in simulating molecular interactions can lead to breakthroughs in understanding complex biological systems, accelerating drug discovery timelines, and enabling more precise predictions of drug behavior. Major biotechnology corporations have boosted their investment in new medication research and development, developing a huge opportunity for drug discovery informatics market expansion. For example, Insilico Medicine established its Insilico Medicine Generative Artificial Intelligence and Quantum Computing R&D Centre in Abu Dhabi in February 2023, making it the largest AI-powered biotechnology research center in the Middle East.

Competitive Landscape

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Players

The competitive landscape of the global drug discovery informatics market is characterized by intense competition and a diverse range of players, including software providers, technology firms, and pharmaceutical companies. The following are some of the leading companies in the market, along with their market share:

Certara
Boehringer Ingelheim International GmbH
Infosys Ltd
Charles River Laboratories
Collaborative Drug Discovery Inc
Eurofins DiscoverX Products
Jubilant Biosys
Selvita
Novo Informatics Pvt Ltd
ChemAxon Ltd
Albany Molecular Research Inc
Oracle
Accenture
Agilent Technologies Inc
Illumina Inc
Others

These major players continuously invest in R&D activities to enhance their informatics solutions, aiming to stay ahead in a rapidly evolving landscape. The market also witnesses partnerships between pharmaceutical companies and informatics solution providers to leverage combined expertise.

In February 2023, Evotec SE expanded its multi-target integrated drug discovery arrangement with data-driven biotech innovation firm Related Sciences. It plans to expand its combined portfolio of drug development prospects through 2030, employing Evotec’s industry-leading capabilities throughout the whole R&D spectrum.

In May 2022, Fujitsu, an ICT supplier, partnered with the Japanese research organization Riken on next-generation IT drug development methods to foster digital improvements in drug discovery.

In April 2022, Iktos, an AI drug design firm, disclosed a partnership with Teijin Pharma to jointly develop a revolutionary platform for small molecular drug development and design.

In July 2020, Ardigen released a neoantigen prediction tool called ArdImmune Vax. It employs cutting-edge analytics and artificial intelligence to identify the optimal set of neoantigens for usage as targets for cancer vaccines or adoptive cell treatments. This method is also well suited to developing vaccinations against infectious diseases.

In March 2020, Deciphex was partnered with Charles River Laboratories International Inc. This strategy is intended to improve drug research and development by integrating digital pathology.

In August 2019, Certara released the 19.6 version of D360, the company’s molecular informatics platform for drug development and discovery. This platform allows a scientific researcher to retrieve, exchange, and analyze data.

Summary of Key Findings

High R&D spending by pharmaceutical and biotechnology companies for drug discovery and development and increased developments in data mining and analytics contribute to the growth of the drug discovery informatics sector.
The market is segmented by software solutions, services, database management, mode of informatics, end-user, application, integration with other technologies, and region.
The preclinical research segment holds a significant share in the drug discovery informatics market, with informatics solutions widely used in target identification, virtual screening, and optimization of lead compounds.
The pharmaceutical industry is the primary contributor to the drug discovery informatics market, with major pharmaceutical companies investing significantly in informatics solutions to enhance their drug discovery pipelines.
The rise of virtual biotech companies, which often rely on external partnerships and outsourcing, has increased market demand for drug discovery informatics solutions that support collaborative and virtual research environments.
The Asia-Pacific region is emerging as a key market for drug discovery informatics, attributed to the growing pharmaceutical and biotechnology sectors and increasing R&D investments in countries like India and China.

Future Outlook

The market is witnessing a shift towards cloud-based informatics solutions, offering scalability, accessibility, and collaboration capabilities, thus facilitating seamless data sharing and analysis.
The emergence of personalized medicine is influencing the drug discovery informatics sector, with a focus on identifying biomarkers and developing targeted therapies tailored to individual patient profiles.
The integration of omics data (genomics, proteomics, metabolomics) is becoming increasingly important in drug discovery informatics, enabling a more comprehensive understanding of biological systems and potential drug targets.

Segmentation

By Software Solutions
- Chemoinformatics Software
- Bioinformatics Software
- LIMS (Laboratory Information Management System)
- Data Mining and Visualization Software
By Services
- In-House Informatics Services
- Outsourced Services
By Database Management
- Chemical Databases
- Biological Databases
By Mode of Informatics
- Structure-Based Drug Design
- Ligand-Based Drug Design
- Target-Based Drug Design
By End-User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations (CROs)
By Application
- Hit Identification and Validation
- Lead Generation and Optimization
- Preclinical and Clinical Development Support
- Personalized Medicine and Biomarker Discovery
By Integration with Other Technologies
- Artificial Intelligence (AI) and Machine Learning (ML)
- High-Throughput Screening (HTS)
- Omics Technologies
By Region
- North America
  - The U.S.
  - Canada
  - Mexico
- Europe
  - Germany
  - France
  - The U.K.
  - Italy
  - Spain
  - Rest of Europe
- Asia Pacific
  - China
  - Japan
  - India
  - South Korea
  - South-east Asia
  - Rest of Asia Pacific
- Latin America
  - Brazil
  - Argentina
  - Rest of Latin America
- Middle East & Africa
  - GCC Countries
  - South Africa
  - Rest of the Middle East and Africa

Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global Drug Discovery Informatics Market
2.1.1. Global Drug Discovery Informatics Market, By Software Solutions
2.1.2. Global Drug Discovery Informatics Market, By Services
2.1.3. Global Drug Discovery Informatics Market, By Database Management
2.1.4. Global Drug Discovery Informatics Market, By Mode of Informatics
2.1.5. Global Drug Discovery Informatics Market, By End-User
2.1.6. Global Drug Discovery Informatics Market, By Application
2.1.7. Global Drug Discovery Informatics Market, By Integration with Other Technologies
2.1.8. Global Drug Discovery Informatics Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Drug Discovery Informatics Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Drug Discovery Informatics Market Drivers
3.2.2. Drug Discovery Informatics Market Restraints
3.2.3. Drug Discovery Informatics Market Opportunities
3.2.4. Major Drug Discovery Informatics Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Software Solutions
3.5.2. Services
3.5.3. Database Management
3.5.4. Mode of Informatics
3.5.5. End-User
3.5.6. Application
3.5.7. Integration with Other Technologies
3.5.8. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global Drug Discovery Informatics Market: Company Market Share, Value 2022
4.1.2. Global Drug Discovery Informatics Market: Top 6 Company Market Share, Value 2022
4.1.3. Global Drug Discovery Informatics Market: Top 3 Company Market Share, Value 2022
4.2. Global Drug Discovery Informatics Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Product Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Product Matrix
4.7. Potential for New Players in the Global Drug Discovery Informatics Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Research and development in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Product Launch
6.5.5. Geographical Expansion
6.5.6. Others
7. Impact Analysis of COVID-19 and Russia – Ukraine War on Drug Discovery Informatics Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Product Mix
7.2.4. Reduced Industrial Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global Drug Discovery Informatics Market, By Software Solutions
8.1. Global Drug Discovery Informatics Market Overview, by Software Solutions
8.1.1. Global Drug Discovery Informatics Market Revenue Share, By Software Solutions, 2022 Vs 2030 (in %)
8.2. Chemoinformatics Software
8.2.1. Global Drug Discovery Informatics Market, By Chemoinformatics Software, By Region, 2017-2030 (US$ Mn)
8.2.2. Market Dynamics for Chemoinformatics Software
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Bioinformatics Software
8.3.1. Global Drug Discovery Informatics Market, By Bioinformatics Software, By Region, 2017-2030 (US$ Mn)
8.3.2. Market Dynamics for Bioinformatics Software
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
8.4. LIMS (Laboratory Information Management System)
8.4.1. Global Drug Discovery Informatics Market, By LIMS (Laboratory Information Management System), By Region, 2017-2030 (US$ Mn)
8.4.2. Market Dynamics for LIMS (Laboratory Information Management System)
8.4.2.1. Drivers
8.4.2.2. Restraints
8.4.2.3. Opportunities
8.4.2.4. Trends
8.5. Data Mining and Visualization Software
8.5.1. Global Drug Discovery Informatics Market, By Data Mining and Visualization Software, By Region, 2017-2030 (US$ Mn)
8.5.2. Market Dynamics for Data Mining and Visualization Software
8.5.2.1. Drivers
8.5.2.2. Restraints
8.5.2.3. Opportunities
8.5.2.4. Trends
9. Global Drug Discovery Informatics Market, By Services
9.1. Global Drug Discovery Informatics Market Overview, by Services
9.1.1. Global Drug Discovery Informatics Market Revenue Share, By Services, 2022 Vs 2030 (in %)
9.2. In-House Informatics Services
9.2.1. Global Drug Discovery Informatics Market, By In-House Informatics Services, By Region, 2017-2030 (US$ Mn)
9.2.2. Market Dynamics for In-House Informatics Services
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Outsourced Services
9.3.1. Global Drug Discovery Informatics Market, By Outsourced Services, By Region, 2017-2030 (US$ Mn)
9.3.2. Market Dynamics for Outsourced Services
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
10. Global Drug Discovery Informatics Market, By Database Management
10.1. Global Drug Discovery Informatics Market Overview, by Database Management
10.1.1. Global Drug Discovery Informatics Market Revenue Share, By Database Management, 2022 Vs 2030 (in %)
10.2. Chemical Databases
10.2.1. Global Drug Discovery Informatics Market, By Chemical Databases, By Region, 2017-2030 (US$ Mn)
10.2.2. Market Dynamics for Chemical Databases
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Biological Databases
10.3.1. Global Drug Discovery Informatics Market, By Biological Databases, By Region, 2017-2030 (US$ Mn)
10.3.2. Market Dynamics for Biological Databases
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
11. Global Drug Discovery Informatics Market, By Mode of Informatics
11.1. Global Drug Discovery Informatics Market Overview, by Mode of Informatics
11.1.1. Global Drug Discovery Informatics Market Revenue Share, By Mode of Informatics, 2022 Vs 2030 (in %)
11.2. Structure-Based Drug Design
11.2.1. Global Drug Discovery Informatics Market, By Structure-Based Drug Design, By Region, 2017-2030 (US$ Mn)
11.2.2. Market Dynamics for Structure-Based Drug Design
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Ligand-Based Drug Design
11.3.1. Global Drug Discovery Informatics Market, By Ligand-Based Drug Design, By Region, 2017-2030 (US$ Mn)
11.3.2. Market Dynamics for Ligand-Based Drug Design
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends
11.4. Target-Based Drug Design
11.4.1. Global Drug Discovery Informatics Market, By Target-Based Drug Design, By Region, 2017-2030 (US$ Mn)
11.4.2. Market Dynamics for Target-Based Drug Design
11.4.2.1. Drivers
11.4.2.2. Restraints
11.4.2.3. Opportunities
11.4.2.4. Trends
12. Global Drug Discovery Informatics Market, By End-User
12.1. Global Drug Discovery Informatics Market Overview, by End-User
12.1.1. Global Drug Discovery Informatics Market Revenue Share, By End-User, 2022 Vs 2030 (in %)
12.2. Pharmaceutical and Biotechnology Companies
12.2.1. Global Drug Discovery Informatics Market, By Pharmaceutical and Biotechnology Companies, By Region, 2017-2030 (US$ Mn)
12.2.2. Market Dynamics for Pharmaceutical and Biotechnology Companies
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Academic and Research Institutes
12.3.1. Global Drug Discovery Informatics Market, By Academic and Research Institutes, By Region, 2017-2030 (US$ Mn)
12.3.2. Market Dynamics for Academic and Research Institutes
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
12.4. Contract Research Organizations (CROs)
12.4.1. Global Drug Discovery Informatics Market, By Contract Research Organizations (CROs), By Region, 2017-2030 (US$ Mn)
12.4.2. Market Dynamics for Contract Research Organizations (CROs)
12.4.2.1. Drivers
12.4.2.2. Restraints
12.4.2.3. Opportunities
12.4.2.4. Trends
13. Global Drug Discovery Informatics Market, By Application
13.1. Global Drug Discovery Informatics Market Overview, by Application
13.1.1. Global Drug Discovery Informatics Market Revenue Share, By Application, 2022 Vs 2030 (in %)
13.2. Hit Identification and Validation
13.2.1. Global Drug Discovery Informatics Market, By Hit Identification and Validation, By Region, 2017-2030 (US$ Mn)
13.2.2. Market Dynamics for Hit Identification and Validation
13.2.2.1. Drivers
13.2.2.2. Restraints
13.2.2.3. Opportunities
13.2.2.4. Trends
13.3. Lead Generation and Optimization
13.3.1. Global Drug Discovery Informatics Market, By Lead Generation and Optimization, By Region, 2017-2030 (US$ Mn)
13.3.2. Market Dynamics for Lead Generation and Optimization
13.3.2.1. Drivers
13.3.2.2. Restraints
13.3.2.3. Opportunities
13.3.2.4. Trends
13.4. Preclinical and Clinical Development Support
13.4.1. Global Drug Discovery Informatics Market, By Preclinical and Clinical Development Support, By Region, 2017-2030 (US$ Mn)
13.4.2. Market Dynamics for Preclinical and Clinical Development Support
13.4.2.1. Drivers
13.4.2.2. Restraints
13.4.2.3. Opportunities
13.4.2.4. Trends
13.5. Personalized Medicine and Biomarker Discovery
13.5.1. Global Drug Discovery Informatics Market, By Personalized Medicine and Biomarker Discovery, By Region, 2017-2030 (US$ Mn)
13.5.2. Market Dynamics for Personalized Medicine and Biomarker Discovery
13.5.2.1. Drivers
13.5.2.2. Restraints
13.5.2.3. Opportunities
13.5.2.4. Trends
14. Global Drug Discovery Informatics Market, By Integration with Other Technologies
14.1. Global Drug Discovery Informatics Market Overview, by Integration with Other Technologies
14.1.1. Global Drug Discovery Informatics Market Revenue Share, By Integration with Other Technologies, 2022 Vs 2030 (in %)
14.2. Artificial Intelligence (AI) and Machine Learning (ML)
14.2.1. Global Drug Discovery Informatics Market, By Artificial Intelligence (AI) and Machine Learning (ML), By Region, 2017-2030 (US$ Mn)
14.2.2. Market Dynamics for Artificial Intelligence (AI) and Machine Learning (ML)
14.2.2.1. Drivers
14.2.2.2. Restraints
14.2.2.3. Opportunities
14.2.2.4. Trends
14.3. High-Throughput Screening (HTS)
14.3.1. Global Drug Discovery Informatics Market, By High-Throughput Screening (HTS), By Region, 2017-2030 (US$ Mn)
14.3.2. Market Dynamics for High-Throughput Screening (HTS)
14.3.2.1. Drivers
14.3.2.2. Restraints
14.3.2.3. Opportunities
14.3.2.4. Trends
14.4. Omics Technologies
14.4.1. Global Drug Discovery Informatics Market, By Omics Technologies, By Region, 2017-2030 (US$ Mn)
14.4.2. Market Dynamics for Omics Technologies
14.4.2.1. Drivers
14.4.2.2. Restraints
14.4.2.3. Opportunities
14.4.2.4. Trends
15. Global Drug Discovery Informatics Market, By Region
15.1. Global Drug Discovery Informatics Market Overview, by Region
15.1.1. Global Drug Discovery Informatics Market, By Region, 2022 vs 2030 (in%)
15.2. Software Solutions
15.2.1. Global Drug Discovery Informatics Market, By Software Solutions, 2017-2030 (US$ Mn)
15.3. Services
15.3.1. Global Drug Discovery Informatics Market, By Services, 2017-2030 (US$ Mn)
15.4. Database Management
15.4.1. Global Drug Discovery Informatics Market, By Database Management, 2017-2030 (US$ Mn)
15.5. Mode of Informatics
15.5.1. Global Drug Discovery Informatics Market, By Mode of Informatics, 2017-2030 (US$ Mn)
15.6. End-User
15.6.1. Global Drug Discovery Informatics Market, By End-User, 2017-2030 (US$ Mn)
15.7. Application
15.7.1. Global Drug Discovery Informatics Market, By Application, 2017-2030 (US$ Mn)
15.8. Integration with Other Technologies
15.8.1. Global Drug Discovery Informatics Market, By Integration with Other Technologies, 2017-2030 (US$ Mn)
16. North America Drug Discovery Informatics Market Analysis
16.1. Overview
16.1.1. Market Dynamics for North America
16.1.1.1. Drivers
16.1.1.2. Restraints
16.1.1.3. Opportunities
16.1.1.4. Trends
16.2. North America Drug Discovery Informatics Market, by Software Solutions, 2017-2030(US$ Mn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. North America Drug Discovery Informatics Market, by Services, 2017-2030(US$ Mn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. North America Drug Discovery Informatics Market, by Database Management, 2017-2030(US$ Mn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. North America Drug Discovery Informatics Market, by Mode of Informatics, 2017-2030(US$ Mn)
16.5.1. Overview
16.5.2. SRC Analysis
16.6. North America Drug Discovery Informatics Market, by End-User, 2017-2030(US$ Mn)
16.6.1. Overview
16.6.2. SRC Analysis
16.7. North America Drug Discovery Informatics Market, by Application, 2017-2030(US$ Mn)
16.7.1. Overview
16.7.2. SRC Analysis
16.8. North America Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2030(US$ Mn)
16.8.1. Overview
16.8.2. SRC Analysis
16.9. North America Drug Discovery Informatics Market, by Country, 2017-2030 (US$ Mn)
16.9.1. North America Drug Discovery Informatics Market, by Country, 2022 Vs 2030 (in%)
16.9.2. U.S.
16.9.3. Canada
16.9.4. Mexico
17. Europe Drug Discovery Informatics Market Analysis
17.1. Overview
17.1.1. Market Dynamics for North America
17.1.1.1. Drivers
17.1.1.2. Restraints
17.1.1.3. Opportunities
17.1.1.4. Trends
17.2. Europe Drug Discovery Informatics Market, by Software Solutions, 2017-2030(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Europe Drug Discovery Informatics Market, by Services, 2017-2030(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Europe Drug Discovery Informatics Market, by Database Management, 2017-2030(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Europe Drug Discovery Informatics Market, by Mode of Informatics, 2017-2030(US$ Mn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. Europe Drug Discovery Informatics Market, by End-User, 2017-2030(US$ Mn)
17.6.1. Overview
17.6.2. SRC Analysis
17.7. Europe Drug Discovery Informatics Market, by Application, 2017-2030(US$ Mn)
17.7.1. Overview
17.7.2. SRC Analysis
17.8. Europe Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2030(US$ Mn)
17.8.1. Overview
17.8.2. SRC Analysis
17.9. Europe Drug Discovery Informatics Market, by Country, 2017-2030 (US$ Mn)
17.9.1. Europe Drug Discovery Informatics Market, by Country, 2022 Vs 2030 (in%)
17.9.2. UK
17.9.3. France
17.9.4. Germany
17.9.5. Italy
17.9.6. Spain
17.9.7. Benelux
17.9.8. Russia
17.9.9. Rest of Europe
18. Asia Pacific Drug Discovery Informatics Market Analysis
18.1. Overview
18.1.1. Market Dynamics for North America
18.1.1.1. Drivers
18.1.1.2. Restraints
18.1.1.3. Opportunities
18.1.1.4. Trends
18.2. Asia Pacific Drug Discovery Informatics Market, by Software Solutions, 2017-2030(US$ Mn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Asia Pacific Drug Discovery Informatics Market, by Services, 2017-2030(US$ Mn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Asia Pacific Drug Discovery Informatics Market, by Database Management, 2017-2030(US$ Mn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Asia Pacific Drug Discovery Informatics Market, by Mode of Informatics, 2017-2030(US$ Mn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Asia Pacific Drug Discovery Informatics Market, by End-User, 2017-2030(US$ Mn)
18.6.1. Overview
18.6.2. SRC Analysis
18.7. Asia Pacific Drug Discovery Informatics Market, by Application, 2017-2030(US$ Mn)
18.7.1. Overview
18.7.2. SRC Analysis
18.8. Asia Pacific Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2030(US$ Mn)
18.8.1. Overview
18.8.2. SRC Analysis
18.9. Asia Pacific Drug Discovery Informatics Market, by Country, 2017-2030 (US$ Mn)
18.9.1. Asia Pacific Drug Discovery Informatics Market, by Country, 2022 Vs 2030 (in%)
18.9.2. China
18.9.3. Japan
18.9.4. India
18.9.5. South Korea
18.9.6. South East Asia
18.9.7. Rest of Asia Pacific
19. Latin America Drug Discovery Informatics Market Analysis
19.1. Overview
19.1.1. Market Dynamics for North America
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. Latin America Drug Discovery Informatics Market, by Software Solutions, 2017-2030(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. Latin America Drug Discovery Informatics Market, by Services, 2017-2030(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. Latin America Drug Discovery Informatics Market, by Database Management, 2017-2030(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. Latin America Drug Discovery Informatics Market, by Mode of Informatics, 2017-2030(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. Latin America Drug Discovery Informatics Market, by End-User, 2017-2030(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. Latin America Drug Discovery Informatics Market, by Application, 2017-2030(US$ Mn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. Latin America Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2030(US$ Mn)
19.8.1. Overview
19.8.2. SRC Analysis
19.9. Latin America Drug Discovery Informatics Market, by Country, 2017-2030 (US$ Mn)
19.9.1. Latin America Drug Discovery Informatics Market, by Country, 2022 Vs 2030 (in%)
19.9.2. Brazil
19.9.3. Argentina
19.9.4. Rest of Latin America
20. Middle East Drug Discovery Informatics Market Analysis
20.1. Overview
20.1.1. Market Dynamics for North America
20.1.1.1. Drivers
20.1.1.2. Restraints
20.1.1.3. Opportunities
20.1.1.4. Trends
20.2. Middle East Drug Discovery Informatics Market, by Software Solutions, 2017-2030(US$ Mn)
20.2.1. Overview
20.2.2. SRC Analysis
20.3. Middle East Drug Discovery Informatics Market, by Services, 2017-2030(US$ Mn)
20.3.1. Overview
20.3.2. SRC Analysis
20.4. Middle East Drug Discovery Informatics Market, by Database Management, 2017-2030(US$ Mn)
20.4.1. Overview
20.4.2. SRC Analysis
20.5. Middle East Drug Discovery Informatics Market, by Mode of Informatics, 2017-2030(US$ Mn)
20.5.1. Overview
20.5.2. SRC Analysis
20.6. Middle East Drug Discovery Informatics Market, by End-User, 2017-2030(US$ Mn)
20.6.1. Overview
20.6.2. SRC Analysis
20.7. Middle East Drug Discovery Informatics Market, by Application, 2017-2030(US$ Mn)
20.7.1. Overview
20.7.2. SRC Analysis
20.8. Middle East Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2030(US$ Mn)
20.8.1. Overview
20.8.2. SRC Analysis
20.9. Middle East Drug Discovery Informatics Market, by Country, 2017-2030 (US$ Mn)
20.9.1. Middle East Drug Discovery Informatics Market, by Country, 2022 Vs 2030 (in%)
20.9.2. UAE
20.9.3. Saudi Arabia
20.9.4. Rest of Middle East
21. Africa Drug Discovery Informatics Market Analysis
21.1. Overview
21.1.1. Market Dynamics for North America
21.1.1.1. Drivers
21.1.1.2. Restraints
21.1.1.3. Opportunities
21.1.1.4. Trends
21.2. Africa Drug Discovery Informatics Market, by Software Solutions, 2017-2030(US$ Mn)
21.2.1. Overview
21.2.2. SRC Analysis
21.3. Africa Drug Discovery Informatics Market, by Services, 2017-2030(US$ Mn)
21.3.1. Overview
21.3.2. SRC Analysis
21.4. Africa Drug Discovery Informatics Market, by Database Management, 2017-2030(US$ Mn)
21.4.1. Overview
21.4.2. SRC Analysis
21.5. Africa Drug Discovery Informatics Market, by Mode of Informatics, 2017-2030(US$ Mn)
21.5.1. Overview
21.5.2. SRC Analysis
21.6. Africa Drug Discovery Informatics Market, by End-User, 2017-2030(US$ Mn)
21.6.1. Overview
21.6.2. SRC Analysis
21.7. Africa Drug Discovery Informatics Market, by Application, 2017-2030(US$ Mn)
21.7.1. Overview
21.7.2. SRC Analysis
21.8. Africa Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2030(US$ Mn)
21.8.1. Overview
21.8.2. SRC Analysis
21.9. Africa Drug Discovery Informatics Market, by Country, 2017-2030 (US$ Mn)
21.9.1. Middle East Drug Discovery Informatics Market, by Country, 2022 Vs 2030 (in%)
21.9.2. South Africa
21.9.3. Egypt
21.9.4. Rest of Africa
22. Company Profiles
22.1. Certara
22.1.1. Company Overview
22.1.2. Products/Services Portfolio
22.1.3. Geographical Presence
22.1.4. SWOT Analysis
22.1.5. Financial Summary
22.1.5.1. Market Revenue and Net Profit (2019-2022)
22.1.5.2. Business Segment Revenue Analysis
22.1.5.3. Geographical Revenue Analysis
22.2. Boehringer Ingelheim International GmbH
22.3. Infosys Ltd
22.4. Charles River Laboratories
22.5. Collaborative Drug Discovery Inc
22.6. Eurofins DiscoverX Products
22.7. Jubilant Biosys
22.8. Selvita
22.9. Novo Informatics Pvt Ltd
22.10. ChemAxon Ltd
22.11. Albany Molecular Research Inc
22.12. Oracle
22.13. Accenture
22.14. Agilent Technologies Inc
22.15. Illumina Inc
22.16. Others
23. Research Methodology
23.1. Research Methodology
23.2. Phase I – Secondary Research
23.3. Phase II – Data Modelling
23.3.1. Company Share Analysis Model
23.3.2. Revenue Based Modelling
23.4. Phase III – Primary Research
23.5. Research Limitations
23.5.1. Assumptions

List of Figures
FIG. 1 Global Drug Discovery Informatics Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom Up Approach
FIG. 3 Global Drug Discovery Informatics Market Segmentation
FIG. 4 Global Drug Discovery Informatics Market, by Software Solutions, 2022 (US$ Mn)
FIG. 5 Global Drug Discovery Informatics Market, by Services, 2022 (US$ Mn)
FIG. 6 Global Drug Discovery Informatics Market, by Database Management, 2022 (US$ Mn)
FIG. 7 Global Drug Discovery Informatics Market, by Mode of Informatics, 2022 (US$ Mn)
FIG. 8 Global Drug Discovery Informatics Market, by End-User, 2022 (US$ Mn)
FIG. 9 Global Drug Discovery Informatics Market, by Application, 2022 (US$ Mn)
FIG. 10 Global Drug Discovery Informatics Market, by Integration with Other Technologies, 2022 (US$ Mn)
FIG. 11 Global Drug Discovery Informatics Market, by Geography, 2022 (US$ Mn)
FIG. 12 Attractive Investment Proposition, by Software Solutions, 2022
FIG. 13 Attractive Investment Proposition, by Services, 2022
FIG. 14 Attractive Investment Proposition, by Database Management, 2022
FIG. 15 Attractive Investment Proposition, by Mode of Informatics, 2022
FIG. 16 Attractive Investment Proposition, by End-User, 2022
FIG. 17 Attractive Investment Proposition, by Application, 2022
FIG. 18 Attractive Investment Proposition, by Integration with Other Technologies, 2022
FIG. 19 Attractive Investment Proposition, by Geography, 2022
FIG. 20 Global Market Share Analysis of Key Drug Discovery Informatics Market Manufacturers, 2022
FIG. 21 Global Market Positioning of Key Drug Discovery Informatics Market Manufacturers, 2022
FIG. 22 Global Drug Discovery Informatics Market Value Contribution, By Software Solutions, 2022 & 2030 (Value %)
FIG. 23 Global Drug Discovery Informatics Market, by Chemoinformatics Software, Value, 2017-2030 (US$ Mn)
FIG. 24 Global Drug Discovery Informatics Market, by Bioinformatics Software, Value, 2017-2030 (US$ Mn)
FIG. 25 Global Drug Discovery Informatics Market, by LIMS (Laboratory Information Management System), Value, 2017-2030 (US$ Mn)
FIG. 26 Global Drug Discovery Informatics Market, by Data Mining and Visualization Software, Value, 2017-2030 (US$ Mn)
FIG. 27 Global Drug Discovery Informatics Market Value Contribution, By Services, 2022 & 2030 (Value %)
FIG. 28 Global Drug Discovery Informatics Market, by In-House Informatics Services, Value, 2017-2030 (US$ Mn)
FIG. 29 Global Drug Discovery Informatics Market, by Outsourced Services, Value, 2017-2030 (US$ Mn)
FIG. 30 Global Drug Discovery Informatics Market Value Contribution, By Database Management, 2022 & 2030 (Value %)
FIG. 31 Global Drug Discovery Informatics Market, by Chemical Databases, Value, 2017-2030 (US$ Mn)
FIG. 32 Global Drug Discovery Informatics Market, by Biological Databases, Value, 2017-2030 (US$ Mn)
FIG. 33 Global Drug Discovery Informatics Market Value Contribution, By Mode of Informatics, 2022 & 2030 (Value %)
FIG. 34 Global Drug Discovery Informatics Market, by Structure-Based Drug Design, Value, 2017-2030 (US$ Mn)
FIG. 35 Global Drug Discovery Informatics Market, by Ligand-Based Drug Design, Value, 2017-2030 (US$ Mn)
FIG. 36 Global Drug Discovery Informatics Market, by Target-Based Drug Design, Value, 2017-2030 (US$ Mn)
FIG. 37 Global Drug Discovery Informatics Market Value Contribution, By End-User, 2022 & 2030 (Value %)
FIG. 38 Global Drug Discovery Informatics Market, by Pharmaceutical and Biotechnology Companies, Value, 2017-2030 (US$ Mn)
FIG. 39 Global Drug Discovery Informatics Market, by Academic and Research Institutes, Value, 2017-2030 (US$ Mn)
FIG. 40 Global Drug Discovery Informatics Market, by Contract Research Organizations (CROs), Value, 2017-2030 (US$ Mn)
FIG. 41 Global Drug Discovery Informatics Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 42 Global Drug Discovery Informatics Market, by Hit Identification and Validation, Value, 2017-2030 (US$ Mn)
FIG. 43 Global Drug Discovery Informatics Market, by Lead Generation and Optimization, Value, 2017-2030 (US$ Mn)
FIG. 44 Global Drug Discovery Informatics Market, by Preclinical and Clinical Development Support, Value, 2017-2030 (US$ Mn)
FIG. 45 Global Drug Discovery Informatics Market, by Personalized Medicine and Biomarker Discovery, Value, 2017-2030 (US$ Mn)
FIG. 46 Global Drug Discovery Informatics Market Value Contribution, By Integration with Other Technologies, 2022 & 2030 (Value %)
FIG. 47 Global Drug Discovery Informatics Market, by Artificial Intelligence (AI) and Machine Learning (ML), Value, 2017-2030 (US$ Mn)
FIG. 48 Global Drug Discovery Informatics Market, by High-Throughput Screening (HTS), Value, 2017-2030 (US$ Mn)
FIG. 49 Global Drug Discovery Informatics Market, by Omics Technologies, Value, 2017-2030 (US$ Mn)
FIG. 50 North America Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 51 U.S. Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 52 Canada Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 53 Mexico Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 54 Europe Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 55 Germany Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 56 France Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 57 U.K. Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 58 Italy Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 59 Spain Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 60 Benelux Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 61 Russia Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 62 Rest of Europe Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 63 Asia Pacific Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 64 China Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 65 Japan Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 66 India Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 67 South Korea Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 68 South-East Asia Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 69 Rest of Asia Pacific Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 70 Latin America Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 71 Brazil Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 72 Argentina Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 73 Rest of Latin America Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 74 Middle East Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 75 UAE Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 76 Saudi Arabia Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 77 Rest of Middle East Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 78 Africa Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 79 South Africa Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 80 Egypt Drug Discovery Informatics Market, 2017-2030 (US$ Mn)
FIG. 81 Rest of Africa Drug Discovery Informatics Market, 2017-2030 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global Drug Discovery Informatics Market
TABLE 2 Global Drug Discovery Informatics Market: Market Drivers Impact Analysis
TABLE 3 Global Drug Discovery Informatics Market: Market Restraints Impact Analysis
TABLE 4 Global Drug Discovery Informatics Market, by Competitive Benchmarking, 2022
TABLE 5 Global Drug Discovery Informatics Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Drug Discovery Informatics Market, by Key Strategies Analysis, 2022
TABLE 7 Global Drug Discovery Informatics Market, by Chemoinformatics Software, By Region, 2017-2022 (US$ Mn)
TABLE 8 Global Drug Discovery Informatics Market, by Chemoinformatics Software, By Region, 2023-2030 (US$ Mn)
TABLE 9 Global Drug Discovery Informatics Market, by Bioinformatics Software, By Region, 2017-2022 (US$ Mn)
TABLE 10 Global Drug Discovery Informatics Market, by Bioinformatics Software, By Region, 2023-2030 (US$ Mn)
TABLE 11 Global Drug Discovery Informatics Market, by LIMS (Laboratory Information Management System), By Region, 2017-2022 (US$ Mn)
TABLE 12 Global Drug Discovery Informatics Market, by LIMS (Laboratory Information Management System), By Region, 2023-2030 (US$ Mn)
TABLE 13 Global Drug Discovery Informatics Market, by Data Mining and Visualization Software, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global Drug Discovery Informatics Market, by Data Mining and Visualization Software, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global Drug Discovery Informatics Market, by In-House Informatics Services, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global Drug Discovery Informatics Market, by In-House Informatics Services, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global Drug Discovery Informatics Market, by Outsourced Services, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global Drug Discovery Informatics Market, by Outsourced Services, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global Drug Discovery Informatics Market, by Chemical Databases, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global Drug Discovery Informatics Market, by Chemical Databases, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global Drug Discovery Informatics Market, by Biological Databases, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global Drug Discovery Informatics Market, by Biological Databases, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global Drug Discovery Informatics Market, by Structure-Based Drug Design, By Region, 2017-2022 (US$ Mn)
TABLE 24 Global Drug Discovery Informatics Market, by Structure-Based Drug Design, By Region, 2023-2030 (US$ Mn)
TABLE 25 Global Drug Discovery Informatics Market, by Ligand-Based Drug Design, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global Drug Discovery Informatics Market, by Ligand-Based Drug Design, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global Drug Discovery Informatics Market, by Target-Based Drug Design, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global Drug Discovery Informatics Market, by Target-Based Drug Design, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global Drug Discovery Informatics Market, by Pharmaceutical and Biotechnology Companies, By Region, 2017-2022 (US$ Mn)
TABLE 30 Global Drug Discovery Informatics Market, by Pharmaceutical and Biotechnology Companies, By Region, 2023-2030 (US$ Mn)
TABLE 31 Global Drug Discovery Informatics Market, by Academic and Research Institutes, By Region, 2017-2022 (US$ Mn)
TABLE 32 Global Drug Discovery Informatics Market, by Academic and Research Institutes, By Region, 2023-2030 (US$ Mn)
TABLE 33 Global Drug Discovery Informatics Market, by Contract Research Organizations (CROs), By Region, 2017-2022 (US$ Mn)
TABLE 34 Global Drug Discovery Informatics Market, by Contract Research Organizations (CROs), By Region, 2023-2030 (US$ Mn)
TABLE 35 Global Drug Discovery Informatics Market, by Hit Identification and Validation, By Region, 2017-2022 (US$ Mn)
TABLE 36 Global Drug Discovery Informatics Market, by Hit Identification and Validation, By Region, 2023-2030 (US$ Mn)
TABLE 37 Global Drug Discovery Informatics Market, by Lead Generation and Optimization, By Region, 2017-2022 (US$ Mn)
TABLE 38 Global Drug Discovery Informatics Market, by Lead Generation and Optimization, By Region, 2023-2030 (US$ Mn)
TABLE 39 Global Drug Discovery Informatics Market, by Preclinical and Clinical Development Support, By Region, 2017-2022 (US$ Mn)
TABLE 40 Global Drug Discovery Informatics Market, by Preclinical and Clinical Development Support, By Region, 2023-2030 (US$ Mn)
TABLE 41 Global Drug Discovery Informatics Market, by Personalized Medicine and Biomarker Discovery, By Region, 2017-2022 (US$ Mn)
TABLE 42 Global Drug Discovery Informatics Market, by Personalized Medicine and Biomarker Discovery, By Region, 2023-2030 (US$ Mn)
TABLE 43 Global Drug Discovery Informatics Market, by Artificial Intelligence (AI) and Machine Learning (ML), By Region, 2017-2022 (US$ Mn)
TABLE 44 Global Drug Discovery Informatics Market, by Artificial Intelligence (AI) and Machine Learning (ML), By Region, 2023-2030 (US$ Mn)
TABLE 45 Global Drug Discovery Informatics Market, by High-Throughput Screening (HTS), By Region, 2017-2022 (US$ Mn)
TABLE 46 Global Drug Discovery Informatics Market, by High-Throughput Screening (HTS), By Region, 2023-2030 (US$ Mn)
TABLE 47 Global Drug Discovery Informatics Market, by Omics Technologies, By Region, 2017-2022 (US$ Mn)
TABLE 48 Global Drug Discovery Informatics Market, by Omics Technologies, By Region, 2023-2030 (US$ Mn)
TABLE 49 Global Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 50 Global Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 51 Global Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 52 Global Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 53 Global Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 54 Global Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 55 Global Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 56 Global Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 57 Global Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 58 Global Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 59 Global Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 60 Global Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 61 Global Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 62 Global Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 63 Global Drug Discovery Informatics Market, by Region, 2017-2022 (US$ Mn)
TABLE 64 Global Drug Discovery Informatics Market, by Region, 2023-2030 (US$ Mn)
TABLE 65 North America Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 66 North America Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 67 North America Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 68 North America Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 69 North America Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 70 North America Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 71 North America Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 72 North America Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 73 North America Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 74 North America Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 75 North America Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 76 North America Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 77 North America Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 78 North America Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 79 North America Drug Discovery Informatics Market, by Country, 2017-2022 (US$ Mn)
TABLE 80 North America Drug Discovery Informatics Market, by Country, 2023-2030 (US$ Mn)
TABLE 81 United States Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 82 United States Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 83 United States Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 84 United States Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 85 United States Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 86 United States Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 87 United States Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 88 United States Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 89 United States Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 90 United States Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 91 United States Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 92 United States Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 93 United States Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 94 United States Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 95 Canada Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 96 Canada Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 97 Canada Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 98 Canada Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 99 Canada Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 100 Canada Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 101 Canada Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 102 Canada Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 103 Canada Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 104 Canada Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 105 Canada Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 106 Canada Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 107 Canada Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 108 Canada Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 109 Mexico Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 110 Mexico Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 111 Mexico Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 112 Mexico Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 113 Mexico Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 114 Mexico Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 115 Mexico Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 116 Mexico Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 117 Mexico Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 118 Mexico Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 119 Mexico Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 120 Mexico Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 121 Mexico Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 122 Mexico Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 123 Europe Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 124 Europe Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 125 Europe Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 126 Europe Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 127 Europe Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 128 Europe Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 129 Europe Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 130 Europe Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 131 Europe Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 132 Europe Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 133 Europe Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 134 Europe Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 135 Europe Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 136 Europe Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 137 Europe Drug Discovery Informatics Market, by Country, 2017-2022 (US$ Mn)
TABLE 138 Europe Drug Discovery Informatics Market, by Country, 2023-2030 (US$ Mn)
TABLE 139 Germany Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 140 Germany Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 141 Germany Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 142 Germany Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 143 Germany Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 144 Germany Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 145 Germany Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 146 Germany Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 147 Germany Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 148 Germany Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 149 Germany Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 150 Germany Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 151 Germany Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 152 Germany Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 153 France Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 154 France Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 155 France Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 156 France Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 157 France Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 158 France Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 159 France Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 160 France Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 161 France Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 162 France Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 163 France Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 164 France Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 165 France Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 166 France Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 167 United Kingdom Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 168 United Kingdom Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 169 United Kingdom Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 170 United Kingdom Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 171 United Kingdom Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 172 United Kingdom Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 173 United Kingdom Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 174 United Kingdom Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 175 United Kingdom Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 176 United Kingdom Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 177 United Kingdom Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 178 United Kingdom Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 179 United Kingdom Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 180 United Kingdom Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 181 Italy Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 182 Italy Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 183 Italy Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 184 Italy Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 185 Italy Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 186 Italy Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 187 Italy Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 188 Italy Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 189 Italy Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 190 Italy Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 191 Italy Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 192 Italy Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 193 Italy Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 194 Italy Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 195 Spain Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 196 Spain Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 197 Spain Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 198 Spain Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 199 Spain Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 200 Spain Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 201 Spain Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 202 Spain Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 203 Spain Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 204 Spain Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 205 Spain Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 206 Spain Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 207 Spain Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 208 Spain Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 209 Benelux Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 210 Benelux Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 211 Benelux Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 212 Benelux Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 213 Benelux Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 214 Benelux Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 215 Benelux Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 216 Benelux Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 217 Benelux Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 218 Benelux Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 219 Benelux Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 220 Benelux Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 221 Benelux Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 222 Benelux Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 223 Russia Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 224 Russia Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 225 Russia Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 226 Russia Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 227 Russia Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 228 Russia Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 229 Russia Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 230 Russia Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 231 Russia Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 232 Russia Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 233 Russia Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 234 Russia Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 235 Russia Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 236 Russia Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 237 Rest of Europe Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 238 Rest of Europe Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 239 Rest of Europe Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 240 Rest of Europe Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 241 Rest of Europe Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 242 Rest of Europe Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 243 Rest of Europe Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 244 Rest of Europe Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 245 Rest of Europe Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 246 Rest of Europe Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 247 Rest of Europe Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 248 Rest of Europe Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 249 Rest of Europe Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 250 Rest of Europe Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 251 Asia Pacific Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 252 Asia Pacific Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 253 Asia Pacific Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 254 Asia Pacific Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 255 Asia Pacific Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 256 Asia Pacific Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 257 Asia Pacific Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 258 Asia Pacific Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 259 Asia Pacific Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 260 Asia Pacific Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 261 Asia Pacific Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 262 Asia Pacific Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 263 Asia Pacific Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 264 Asia Pacific Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 265 China Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 266 China Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 267 China Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 268 China Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 269 China Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 270 China Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 271 China Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 272 China Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 273 China Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 274 China Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 275 China Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 276 China Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 277 China Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 278 China Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 279 Japan Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 280 Japan Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 281 Japan Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 282 Japan Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 283 Japan Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 284 Japan Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 285 Japan Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 286 Japan Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 287 Japan Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 288 Japan Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 289 Japan Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 290 Japan Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 291 Japan Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 292 Japan Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 293 India Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 294 India Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 295 India Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 296 India Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 297 India Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 298 India Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 299 India Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 300 India Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 301 India Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 302 India Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 303 India Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 304 India Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 305 India Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 306 India Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 307 South Korea Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 308 South Korea Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 309 South Korea Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 310 South Korea Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 311 South Korea Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 312 South Korea Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 313 South Korea Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 314 South Korea Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 315 South Korea Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 316 South Korea Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 317 South Korea Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 318 South Korea Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 319 South Korea Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 320 South Korea Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 321 South-East Asia Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 322 South-East Asia Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 323 South-East Asia Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 324 South-East Asia Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 325 South-East Asia Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 326 South-East Asia Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 327 South-East Asia Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 328 South-East Asia Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 329 South-East Asia Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 330 South-East Asia Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 331 South-East Asia Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 332 South-East Asia Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 333 South-East Asia Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 334 South-East Asia Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 335 Rest of Asia Pacific Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 336 Rest of Asia Pacific Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 337 Rest of Asia Pacific Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 338 Rest of Asia Pacific Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 339 Rest of Asia Pacific Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 340 Rest of Asia Pacific Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 341 Rest of Asia Pacific Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 342 Rest of Asia Pacific Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 343 Rest of Asia Pacific Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 344 Rest of Asia Pacific Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 345 Rest of Asia Pacific Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 346 Rest of Asia Pacific Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 347 Rest of Asia Pacific Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 348 Rest of Asia Pacific Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 349 Latin America Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 350 Latin America Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 351 Latin America Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 352 Latin America Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 353 Latin America Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 354 Latin America Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 355 Latin America Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 356 Latin America Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 357 Latin America Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 358 Latin America Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 359 Latin America Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 360 Latin America Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 361 Latin America Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 362 Latin America Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 363 Brazil Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 364 Brazil Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 365 Brazil Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 366 Brazil Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 367 Brazil Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 368 Brazil Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 369 Brazil Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 370 Brazil Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 371 Brazil Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 372 Brazil Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 373 Brazil Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 374 Brazil Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 375 Brazil Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 376 Brazil Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 377 Argentina Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 378 Argentina Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 379 Argentina Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 380 Argentina Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 381 Argentina Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 382 Argentina Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 383 Argentina Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 384 Argentina Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 385 Argentina Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 386 Argentina Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 387 Argentina Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 388 Argentina Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 389 Argentina Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 390 Argentina Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 391 Rest of Latin America Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 392 Rest of Latin America Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 393 Rest of Latin America Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 394 Rest of Latin America Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 395 Rest of Latin America Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 396 Rest of Latin America Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 397 Rest of Latin America Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 398 Rest of Latin America Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 399 Rest of Latin America Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 400 Rest of Latin America Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 401 Rest of Latin America Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 402 Rest of Latin America Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 403 Rest of Latin America Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 404 Rest of Latin America Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 405 Middle East Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 406 Middle East Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 407 Middle East Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 408 Middle East Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 409 Middle East Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 410 Middle East Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 411 Middle East Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 412 Middle East Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 413 Middle East Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 414 Middle East Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 415 Middle East Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 416 Middle East Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 417 Middle East Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 418 Middle East Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 419 UAE Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 420 UAE Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 421 UAE Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 422 UAE Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 423 UAE Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 424 UAE Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 425 UAE Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 426 UAE Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 427 UAE Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 428 UAE Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 429 UAE Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 430 UAE Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 431 UAE Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 432 UAE Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 433 Saudi Arabia Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 434 Saudi Arabia Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 435 Saudi Arabia Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 436 Saudi Arabia Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 437 Saudi Arabia Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 438 Saudi Arabia Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 439 Saudi Arabia Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 440 Saudi Arabia Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 441 Saudi Arabia Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 442 Saudi Arabia Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 443 Saudi Arabia Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 444 Saudi Arabia Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 445 Saudi Arabia Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 446 Saudi Arabia Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 447 Rest of Middle East Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 448 Rest of Middle East Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 449 Rest of Middle East Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 450 Rest of Middle East Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 451 Rest of Middle East Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 452 Rest of Middle East Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 453 Rest of Middle East Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 454 Rest of Middle East Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 455 Rest of Middle East Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 456 Rest of Middle East Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 457 Rest of Middle East Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 458 Rest of Middle East Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 459 Rest of Middle East Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 460 Rest of Middle East Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 461 Africa Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 462 Africa Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 463 Africa Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 464 Africa Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 465 Africa Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 466 Africa Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 467 Africa Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 468 Africa Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 469 Africa Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 470 Africa Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 471 Africa Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 472 Africa Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 473 Africa Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 474 Africa Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 475 South Africa Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 476 South Africa Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 477 South Africa Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 478 South Africa Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 479 South Africa Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 480 South Africa Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 481 South Africa Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 482 South Africa Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 483 South Africa Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 484 South Africa Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 485 South Africa Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 486 South Africa Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 487 South Africa Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 488 South Africa Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 489 Egypt Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 490 Egypt Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 491 Egypt Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 492 Egypt Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 493 Egypt Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 494 Egypt Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 495 Egypt Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 496 Egypt Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 497 Egypt Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 498 Egypt Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 499 Egypt Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 500 Egypt Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 501 Egypt Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 502 Egypt Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)
TABLE 503 Rest of Africa Drug Discovery Informatics Market, by Software Solutions, 2017-2022 (US$ Mn)
TABLE 504 Rest of Africa Drug Discovery Informatics Market, by Software Solutions, 2023-2030 (US$ Mn)
TABLE 505 Rest of Africa Drug Discovery Informatics Market, by Services, 2017-2022 (US$ Mn)
TABLE 506 Rest of Africa Drug Discovery Informatics Market, by Services, 2023-2030 (US$ Mn)
TABLE 507 Rest of Africa Drug Discovery Informatics Market, by Database Management, 2017-2022 (US$ Mn)
TABLE 508 Rest of Africa Drug Discovery Informatics Market, by Database Management, 2023-2030 (US$ Mn)
TABLE 509 Rest of Africa Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2017-2022 (US$ Mn)
TABLE 510 Rest of Africa Drug Discovery Informatics Market, by Mode of Informatics, By Region, 2023-2030 (US$ Mn)
TABLE 511 Rest of Africa Drug Discovery Informatics Market, by End-User, 2017-2022 (US$ Mn)
TABLE 512 Rest of Africa Drug Discovery Informatics Market, by End-User, 2023-2030 (US$ Mn)
TABLE 513 Rest of Africa Drug Discovery Informatics Market, by Application, 2017-2022 (US$ Mn)
TABLE 514 Rest of Africa Drug Discovery Informatics Market, by Application, 2023-2030 (US$ Mn)
TABLE 515 Rest of Africa Drug Discovery Informatics Market, by Integration with Other Technologies, 2017-2022 (US$ Mn)
TABLE 516 Rest of Africa Drug Discovery Informatics Market, by Integration with Other Technologies, 2023-2030 (US$ Mn)

What is the current size of the global drug discovery informatics market?

The global drug discovery informatics market was valued at USD 3215.5 Million in 2022.

What is the expected growth rate of the drug discovery informatics market between 2023 and 2030?

The drug discovery informatics market is predicted to grow at a CAGR of 11.5% between 2023 and 2030, reaching USD 7681.5 Million in 2030.

Which segment is leading the market revenue share in terms of informatics mode?

Structure-based drug design is the leading mode of the informatics segment, holding over 40% share in value in 2022.

Which software solutions segment governs the global demand for drug discovery informatics?

The bioinformatics software solutions segment governs the global demand for drug discovery informatics, holding a massive market share of over 30% in 2022.

Which application segment is expected to have the strongest CAGR across the projection period?

The personalized medicine and biomarker discovery segment will post the fastest market CAGR.

Purchase Options

Single User

$4699

Multi User

$5699

Custom Report

$7699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –